Oxford Pharmascience Group (OXP)

 

Latest News

Oxford Pharmascience issues company update

Oxford Pharmascience Group has provided a company update, the highlights of which are given below: - Dosing commen...

Company Update

RNS Number: 3020U Oxford Pharmascience Group PLC 17 January 2017 Technical, Clinical and Regulatory Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take, provides the following update. Highlights Dosing commenced in the Phase I exploratory phar...

R&D Update

RNS Number: 6768O Oxford Pharmascience Group PLC 09 November 2016 Oxford Pharmascience Group plc ("Oxford Pharmascience" or the "Company") R&D Update Oxford Pharmascience Group plc (AIM: OXP), the specialty pharmaceutical company that redevelops medicines to make them better, safer and easier to take provides the following update on the d...

Here's what Neil Woodford is buying and selling

September proved a mixed month for Neil Woodford. Lee Wild reveals what the star fund manager was trading last mon...

All News

DateHeadlineSource
17-01-17Oxford Pharmascience issues company updateStockMarketWire
17-01-17Company UpdateRNS
09-11-16R&D UpdateRNS
19-10-16Here's what Neil Woodford is buying and sellingInteractive Investor
13-09-16Oxford Pharmascience - Interim results 2016BRR Media
07-09-16Interim results for the 6 months to 30 June 2016RNS
21-07-16Oxford Pharmascience downgraded by BeaufortStockMarketWire
21-07-16Broker Forecast - Beaufort Securities issues a broker note on Oxford Pharmascience Group PLCStockMarketWire
20-07-16FTSE rises on pharmas, financials as miners ebbStockMarketWire
20-07-16Commercial Update & Directorate ChangeRNS
22-06-16Result of AGMRNS
20-05-16Shares Magazine Investor Evening PresentationRNS
22-04-16OXP to exhibit at the Master Investor Show 2016RNS
22-04-16Oxford Pharmascience Group plc - Company updateBRR Media
19-04-16Positive Regulatory Advice from MHRARNS
11-03-16Grant of Share OptionsRNS
04-03-16Oxford Pharmascience widens FY pretax lossStockMarketWire
04-03-16Final ResultsRNS
01-03-16Oxford Pharmascience schedules FY results StockMarketWire
01-03-16Notice of ResultsRNS
25-02-16Appointment of DirectorRNS
29-01-16Change of Registered OfficeRNS
25-01-16OXP primed for partnering talks on OXPzero NSAIDSStockMarketWire
25-01-16Entering Partnering DiscussionsRNS
04-12-15Oxford Pharmascience CFO granted share optionsStockMarketWire
04-12-15Grant of Share OptionsRNS
01-12-15Holding(s) in CompanyRNS
05-11-15OXP updates on OXPzero Ibuprofen StockMarketWire
05-11-15Successful Completion of PoC for OXPzero IbuprofenRNS
05-11-15Oxford Pharmascience - Successful completion of PoC for OXPzero Ibuprofen BRR Media
22-09-15Interim results for the 6 months to 30 June 2015RNS
16-09-15Notice of Interim ResultsRNS
12-08-15Preliminary PK Data & Initiation of Further StudyRNS
12-08-15Preliminary PK Data & Initiation of Further StudyBRR Media
31-07-15Results from Pilot Clinical Study of OXP500RNS
16-07-15Initiation of Pilot Clinical Study for IbuprofenRNS
16-07-15Initiation of Pilot Clinical StudyRNS
06-07-15Holding(s) in CompanyRNS
30-06-15Holding(s) in CompanyRNS
30-06-15Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:OXP Editorial
  • Regulatory news feed for LSE:OXP Regulatory